Similarly, the study using an S-nitrosated human serum albumin dimer was recently published, showing the synergistic effect when used as a pretreatment agent in albumin-bound paclitaxel nanoparticle (Abraxane®) therapy carried on various tumor models [111,112]. This evidence concerns the gene ALB and neoplasm.